Reference health
Bispecific T-Cell Engaging Antibodies for Cancer Therapy
20/20 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
2 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 20 checked references that resolve
resolves10.1073/pnas.92.15.7021
A small bispecific antibody construct expressed as a functional single-chain molecule with high tumor cell cytotoxicity.
resolves10.1002/ijc.10557
Extremely potent, rapid and costimulation‐independent cytotoxic T‐cell response against lymphoma cells catalyzed by a single‐chain bispecific antibody
resolves10.1097/CJI.0b013e318156750c
Strictly Target Cell-dependent Activation of T Cells by Bispecific Single-chain Antibody Constructs of the BiTE Class
resolves10.1126/science.1158545
Tumor Regression in Cancer Patients by Very Low Doses of a T Cell–Engaging Antibody
resolves10.1182/blood.V112.11.1926.1926
Treatment with Anti-CD19 BiTE Antibody Blinatumomab (MT103 / MEDI-538) Is Able to Eliminate Minimal Residual Disease (MRD) in Patients with B-Precursor Acute Lymphoblastic Leukemia (ALL): First Results of An Ongoing Phase II Study.
resolves10.1016/j.molimm.2005.07.034
MT110: A novel bispecific single-chain antibody construct with high efficacy in eradicating established tumors
resolves10.1126/science.1129139
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
resolves10.1158/1078-0432.CCR-06-1734
CD8+ T-Cell Content in Diagnostic Lymph Nodes Measured by Flow Cytometry Is a Predictor of Survival in Follicular Lymphoma
resolves10.1146/annurev.immunol.25.022106.141609
Immunosuppressive Strategies that are Mediated by Tumor Cells
resolves10.1158/0008-5472.CAN-04-1341
High Frequency of Functionally Active Melan-A–Specific T Cells in a Patient with Progressive Immunoproteasome-Deficient Melanoma
resolves10.1084/jem.20061890
In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor
The 2 references without a DOI — listed, not checked
no DOI — not checkedKontermann RE, Müller D. Recombinant bispecific antibodies for cellular cancer immunotherapy. Curr Opin Mol Ther 2007; 9: 319–26.
no DOI — not checkedBaeuerle PA, Kufer P, Bargou R. BiTE: Teaching antibodies to engage T cells for cancer therapy. Curr Opin Mol Ther 2009; 11: 22–30.
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1158/0008-5472.can-09-0547"><img src="https://citestamp.com/citestamped/10.1158/0008-5472.can-09-0547/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1158/0008-5472.can-09-0547)